UNSPSC 41151630: Laboratory screening test kit

Screening test is done to detect potential health disorders or diseases in people who do not have any symptoms of disease. The goal is early detection and lifestyle changes or surveillance, to reduce the risk of disease, or to detect it early enough to treat it most effectively. Kit also contains primers and probes.

UNSPSC 41151630 Laboratory screening test kit (Commodity) covers diagnostic reagents and reference materials that state and local forensic laboratories, public health agencies, and criminal justice departments use for drug analysis, pathogen detection, and toxicology work. Recent solicitations show concrete buying patterns: Texas Department of Public Safety is procuring Direct ELISA testing kits for substance screening across 12 drug categories (cannabinoids, opiates, PCP, amphetamines, and others); Pinellas County, Florida is acquiring certified reference materials and drug standards for forensic laboratory method validation and evidentiary sample analysis; and Texas Health and Human Services Commission is seeking QIAxcel and QIAamp DNA screening kits for state laboratory DNA fragment evaluation. Issuing bodies include state law enforcement and criminal justice agencies, county forensic laboratories, and state health departments, with repeat activity from Texas agencies across multiple procurement cycles.

Geographic concentration is strongest in Texas and Florida based on recent postings. Representative opportunities include the Texas Department of Public Safety IFB 405-26R0008445A for immunalysis reagent kits (response due July 23, 2026), Pinellas County's ITQ 26-0305-ITQ for certified drug standards under federal Coverdell grant funding with SBE preference (closed April 23, 2026, with approximately $49,034 allocated for equipment and supplies), and Texas Health and Human Services Commission's IFB HHS0016902v2 for DNA screening kits with historical fiscal year 2025 purchasing between $25,050 and $30,000 (response deadline January 29, 2026). The Illinois Department of Financial and Professional Regulation established a joint purchase master contract for mosquito testing equipment including RAMP West Nile Virus and Dengue test kits available to multiple jurisdictions nationwide. Qualification barriers are moderate: Texas agencies enforce vendor performance rating minimums and require financial documentation; Florida requires ISO/IEC 17025 accreditation for certified materials; and controlled-substance reagents require DEA licensing coordination.